| n/a | | | Investors in Material Science (Seed), Investors in AI (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series A), Investors in Seattle / Portland (Other Lists), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Seed), Investors in AI (Seed), Investors in Space (Series A), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Space (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Space (Series A), Investors in AI (Series B), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in British Columbia (Other Lists), Investors in Space (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Series B), Investors in Space (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Therapeutics (Series A), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in AI (Seed) +245 |
MC | n/a | | | Investors in Wellness & Fitness (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Entertainment & Sports (Seed), Investors in Media/Content (Seed), Investors in Space (Seed), Investors in FinTech (Seed), Investors in Media/Content (Seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in Space (Seed), Investors in Colorado / Utah (Other Lists), Investors in Web3/Crypto (Seed), Investors in Entertainment & Sports (Seed), Investors in Entertainment & Sports (Seed), Investors in Space (Seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Blockchain (Seed), Investors in FinTech (Seed), Investors in Wellness & Fitness (Seed), Investors in Entertainment & Sports (Pre-seed), Investors in SaaS (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Wellness & Fitness (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Web3/Blockchain (Seed), Investors in Web3/Crypto (Seed), Investors in Media/Content (Seed), Investors in BioTech (Seed), Investors in Media/Content (Pre-seed), Investors in Web3/Blockchain (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Space (Seed), Investors in Web3/Crypto (Seed), Investors in Entertainment & Sports (Seed), Investors in Media/Content (Seed), Investors in Web3/Crypto (Pre-seed), Investors in FinTech (Seed), Investors in Therapeutics (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Space (Pre-seed), Investors in Wellness & Fitness (Seed), Investors in Web3/Crypto (Pre-seed), Investors in SaaS (Pre-seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Web3/Blockchain (Seed), Investors in Media/Content (Pre-seed), Investors in Therapeutics (Seed), Investors in FinTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Media/Content (Pre-seed), Investors in SaaS (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Space (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in BioTech (Seed), Investors in Entertainment & Sports (Pre-seed), Investors in FinTech (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Space (Pre-seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Pre-seed), Investors in BioTech (Pre-seed), Investors in San Francisco Bay Area (Other Lists), Investors in Space (Pre-seed), Investors in SaaS (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Therapeutics (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Therapeutics (Seed), Investors in Media/Content (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in SaaS (Seed) +82 |